Last quarter (Q3 2023), Urogen Pharma's total revenue was $20.85M, an increase of 29.54% from the same quarter last year. In Q3, Urogen Pharma's net income was $-17.31M. See Urogen Pharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 77.28M	$ 64.36M	$ 48.04M	$ 11.80M	$ 18.00K	$ 1.13M
Cost of Revenue	$ 282.00K	$ 7.65M	$ 5.16M	$ 1.01M	$ 0.00	$ 1.80M
Gross Profit	$ 67.94M	$ 56.70M	$ 42.88M	$ 10.79M	$ 18.00K	$ -675.00K
Operating Expense	$ 87.17M	$ 135.74M	$ 135.18M	$ 137.53M	$ 109.50M	$ 76.50M
Operating Income	$ -12.26M	$ -79.04M	$ -92.29M	$ -126.74M	$ -109.48M	$ -77.18M
Net Non Operating Interest Income Expense	$ -13.95M	$ -7.43M	$ 212.00K	$ 1.63M	$ 4.33M	$ 1.87M
Other Income Expense	$ -71.00K	$ -72.00K	$ -212.00K	-	$ -284.00K	$ -224.00K
Pretax Income	$ -104.34M	$ -108.03M	$ -109.37M	$ -125.11M	$ -105.15M	$ -75.53M
Tax Provision	$ 755.00K	$ 1.75M	$ 1.45M	$ 3.37M	$ 0.00	$ 125.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -22.68M	$ -88.22M	$ -110.82M	$ -128.48M	$ -105.15M	$ -75.66M
Basic EPS	$ -4.26	$ -4.81	$ -4.96	$ -5.90	$ -5.12	$ -4.80
Diluted EPS	$ -3.01	$ -4.81	$ 0.00	$ -5.90	$ -5.12	$ -4.80
Basic Average Shares	$ 101.85M	$ 22.81M	$ 22.35M	$ 21.78M	$ 20.53M	$ 15.75M
Diluted Average Shares	$ 79.04M	$ 22.81M	$ 22.35M	$ 21.78M	$ 20.53M	$ 15.75M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 87.45M	$ 143.40M	$ 140.33M	$ 138.54M	$ 109.50M	$ 78.31M
Net Income From Continuing And Discontinued Operation	$ -105.10M	$ -109.78M	$ -110.82M	$ -128.48M	$ -105.15M	$ -75.66M
Normalized Income	$ -38.48M	$ -77.69M	-	$ -128.48M	$ -105.15M	$ -75.58M
Interest Expense	-	-	-	-	-	-
EBIT	$ -90.39M	$ -99.59M	$ -92.08M	$ -126.74M	$ -109.48M	$ -77.18M
EBITDA	$ -52.17M	$ -96.52M	$ -89.83M	$ -124.69M	$ -108.15M	$ -76.76M

Currency in USD

Urogen Pharma Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing